Senti Biosciences Holdings, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-58.7M | $31.0M |
| FY2021 | — | $0 | $0 |
| FY2022 | — | $127.3M | $57.6M |
| FY2023 | — | $66.9M | $35.9M |
| FY2024 | — | $25.6M | $48.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-58.7M | $31.0M |
| FY2021 | — | $0 | $0 |
| FY2022 | — | $127.3M | $57.6M |
| FY2023 | — | $66.9M | $35.9M |
| FY2024 | — | $25.6M | $48.3M |